Skip to main content
ACA
NYSE Manufacturing

Arcosa Q2 Revenue Misses Consensus, but Adjusted EBITDA Climbs 5%; Merger Vote Set for Sept 4

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Engineering & Construction Stocks · Industrial
Sentiment info
Neutral
Importance info
8
Price
$145.32
Mkt Cap
$7.123B
52W Low
$83.815
52W High
$146.92
52W Position info
73% above low
Off High info
1.1% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

ACA sits 73% above its 52-week low of $83.815.

Summary

Arcosa reported Q2 2026 revenue of $658.7M, missing consensus, but adjusted EBITDA grew 5% to $145.9M. The pending $150/share acquisition by CRH is proceeding, with a shareholder vote set for September 4, 2026.


Key Events · Earnings and Guidance · ACA

  • Q2 Revenue Misses Consensus

    Revenue of $658.7M grew 2% YoY but fell short of the $687.5M consensus, pressured by wet weather in Texas and lower planned wind tower volumes.

  • Adjusted EBITDA Grows 5%

    Adjusted EBITDA from continuing operations reached $145.9M, a 5% increase, with margin expanding 60 bps to 22.1%, driven by utility structures strength.

  • Utility Backlog Hits Record

    Utility and related structures backlog surged to $648.1M, up 49% from the start of 2026, with 71% expected to be recognized this year.

  • Merger Vote Set for September 4

    The special meeting to approve the $150/share all-cash acquisition by CRH is scheduled for September 4, 2026; the definitive proxy was mailed August 4.


Analysis · ACA · Manufacturing

Arcosa's Q2 revenue of $658.7M missed the $687.5M consensus, driven by weather disruptions and lower wind tower volumes. However, adjusted EBITDA rose 5% to $145.9M with margin expansion, and the utility structures backlog hit a record $648.1M, up 49% year-to-date. The pending $150/share all-cash acquisition by CRH remains on track, with the shareholder vote scheduled for September 4, 2026. The company suspended guidance, making the merger outcome the primary value driver. The earnings miss is notable but overshadowed by the merger's fixed $150/share price, which caps upside and limits downside reaction to operational results.

At the time of this filing, ACA was trading at $145.32 on NYSE in the Manufacturing sector, with a market capitalization of approximately $7.1B. The 52-week trading range was $83.82 to $146.92. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ACA - Latest Insights

ACA
Aug 05, 2026, 4:44 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $145.32
Real-time Price: $145.32 info
Change: $0 (0%) info
Market Cap: $7.123B info
ACA
Aug 05, 2026, 4:23 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $145.32
Real-time Price: $145.32 info
Change: $0 (0%) info
Market Cap: $7.123B info
ACA
Aug 03, 2026, 6:07 AM EDT
Filing Type: DEFM14A
Importance Score:
7
Price at Filing: $145.54
Real-time Price: $145.32 info
Change: -$0.220 (-0.15%) info
Market Cap: $7.123B info
ACA
Jun 22, 2026, 4:02 PM EDT
Filing Type: DEFA14A
Importance Score:
10
Price at Filing: $144.90
Real-time Price: $145.32 info
Change: +$0.420 (+0.29%) info
Market Cap: $7.123B info
ACA
Jun 22, 2026, 4:01 PM EDT
Filing Type: DEFA14A
Importance Score:
10
Price at Filing: $144.90
Real-time Price: $145.32 info
Change: +$0.420 (+0.29%) info
Market Cap: $7.123B info